RT Journal Article
SR Electronic
T1 Low-density lipoprotein cholesterol levels are associated with poor clinical outcomes in COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.06.20207092
DO 10.1101/2020.10.06.20207092
A1 Aparisi, Álvaro
A1 Iglesias-Echeverría, Carolina
A1 Ybarra-Falcón, Cristina
A1 Cusácovich, Iván
A1 Uribarri, Aitor
A1 García-Gómez, Mario
A1 Ladrón, Raquel
A1 Fuertes, Raúl
A1 Candela, Jordi
A1 Hinojosa, Williams
A1 Dueñas, Carlos
A1 González, Roberto
A1 Nogales, Leonor
A1 Calvo, Dolores
A1 Carrasco-Moraleja, Manuel
A1 Román, J. Alberto San
A1 Amat-Santos, Ignacio J.
A1 Andaluz-Ojeda, David
YR 2020
UL http://medrxiv.org/content/early/2020/10/08/2020.10.06.20207092.abstract
AB Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the sole causative agent of coronavirus infectious disease-19 (COVID-19).Methods We performed a retrospective single-center study of consecutively admitted patients between March 1st and May 15th, 2020, with a definitive diagnosis of SARS-CoV-2 infection. The primary end-point was to evaluate the association of lipid markers with 30-days all-cause mortality in COVID-19.Results A total of 654 patients were enrolled, with an estimated 30-day mortality of 22.8% (149 patients). Non-survivors had lower total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-c) levels during the entire course of the disease with complete resolution among survivors. Both showed a significant inverse correlation with inflammatory markers and a positive correlation with lymphocyte count. In a multivariate analysis, LDL-c ≤ 69 mg/dl (hazard ratio [HR] 1.94; 95% confidence interval [CI] 1.14-3.31), C-reactive protein > 88 mg/dl (HR 2.44; 95% CI, 1.41-4.23) and lymphopenia < 1,000 (HR 2.68; 95% CI, 1.91-3.78) at admission were independently associated with 30-day mortality. This association was maintained 7 days after admission.Conclusion Hypolipidemia in SARS-CoV-2 infection may be secondary to an immune-inflammatory response, with complete recovery in survivors. Low LDL-c serum levels are independently associated with higher 30-day mortality in COVID-19 patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was partially funded by Gerencia Regional de Salud de Castilla y Leon under grant number GRS COVID 111/A/20 and GRS COVID 108/A/20Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The local ethics committees approved the study protocol. Informed consent was waived, given the ambispective and observational nature of the study. The work was carried out by following the guidelines of the Declaration of Helsinki of the World Medical Association.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll labor data in this work are real and are available in electronic format to external reviewers and external evaluators however there is no linked URL.ALTAlanine aminotransferaseASTAspartate aminotransferaseAUROCArea under the receiver operating characteristic curve analysisCoQ10Coenzyme Q10COVID-19Coronavirus disease 2019CRPC-Reactive proteinHDL-cHigh-density lipoprotein cholesterolIL6Interleukin 6LDHLactate dehydrogenaseLDL-cLow-density lipoprotein cholesterolPCTProcalcitoninRT-PCRReverse transcription-polymerase chain reactionSARS-CoV-2Severe acute respiratory syndrome coronavirus 2TCTotal cholesterolTGTriglycerides